David M. Axelrod, M.D., clinical associate professor in pediatrics (cardiology) at Stanford School of Medicine, explains ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
John Rumsfeld, M.D., Ph.D., FACC, American College Cardiology (ACC) chief innovation officer, and professor of medicine ...
June 20, 2019 — A new type of care for cardiac patients at St. Paul’s Hospital, Vancouver, has the potential to reduce h ...
Anthony Chang, M.D., chief artificial intelligence officer, Children’s Hospital of Orange County (CHOC), and founder, AI ...
June 17, 2019 – Results from a first-in-man proof of concept study found occlusion of the superior vena cava (SVC) ...
June 14, 2019 — Quantum Genomics announced the enrollment of the first patient in its QUORUM Phase IIb study of its lead ...
June 13, 2019 — Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and ...
June 12, 2019 — Boston Scientific Corp. has initiated the OPTION trial to compare safety and effectiveness of the next ...
June 12, 2019 — In a letter sent to healthcare providers, the U.S. Food and Drug Administration (FDA) validates that ...
June 11, 2019 — Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma addressed the American ...
June 11, 2019 — Abbott recently announced positive late-breaking data from its TRILUMINATE study of the company's ...
June 10, 2019 – W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration’s (FDA’s) premarket ...
June 6, 2019 — Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the ...
June 4, 2019 — Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato I ...
June 20, 2019